
|Articles|June 18, 2007
Latebreakers: Revision made of Actos label
A request from the FDA has led to a revision of the prescribing information for pioglitazone (Actos, Takeda Pharmaceuticals).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Bepirovirsen Meets Primary End Point for Functional Cure Rate of Hepatitis B
2
HHS Limits Vaccine Recommendations for Childhood Schedules
3
GoodRx Offers Wegovy Weight-Loss Pill at Under $150 a Month
4
The PBM Putting Pharmacists at the Center of Formulary Design
5










































































































































































































